BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Company News  |  Deals

Debiopharm S.A., Marina Biotech deal

Debiopharm received exclusive, worldwide rights to Marina's preclinical RNAi-based therapy program for non-muscle invasive bladder cancer. The companies will jointly...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >